N. M. Sanli Et Al. , "Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)," UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.32, no.1, pp.8-15, 2022
Sanli, N. M. Et Al. 2022. Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT). UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.32, no.1 , 8-15.
Sanli, N. M., KEKLİK, M., & ÜNAL, A., (2022). Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT). UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.32, no.1, 8-15.
Sanli, Neslihan, MUZAFFER KEKLİK, And ALİ ÜNAL. "Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)," UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.32, no.1, 8-15, 2022
Sanli, Neslihan M. Et Al. "Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)." UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.32, no.1, pp.8-15, 2022
Sanli, N. M. KEKLİK, M. And ÜNAL, A. (2022) . "Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)." UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.32, no.1, pp.8-15.
@article{article, author={Neslihan Mandaci Sanli Et Al. }, title={Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)}, journal={UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi}, year=2022, pages={8-15} }